AI assistant
Sending…
Tango Therapeutics, Inc. — Director's Dealing 2020
Sep 3, 2020
32459_dirs_2020-09-03_9d039284-e360-460c-a644-5b44b8ed6ad9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BCTG Acquisition Corp. (BCTG)
CIK: 0001819133
Period of Report: 2020-09-02
Reporting Person: Fuglesang Christopher (Director, President)
More from Tango Therapeutics, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Board/Management Information
2026
May 13
Board/Management Information
2026
May 8
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Board/Management Information
2026
Apr 15
Director's Dealing
2026
Mar 28
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Feb 27
Major Shareholding Notification
2026
Feb 17